Latest news with #Iodine
Business Wire
15-05-2025
- Business
- Business Wire
Iodine Software Launches Next-Generation Pre-Bill Solution to Help Health Systems Right-Size Reimbursement
AUSTIN, Texas--(BUSINESS WIRE)--Iodine Software, the leader in healthcare AI for revenue cycle optimization, today launched the next generation of its pre-bill solution, AwarePre-Bill, designed to help health systems close critical revenue gaps before claims are submitted. Built on years of proven success, the solution enables health systems to conduct financially targeted retrospective reviews, improving code accuracy and documentation to help right-size reimbursement. With Iodine, clients have captured $3–4 million per month in previously missed revenue. The launch comes at a time when health systems are under immense financial pressure. Claims denials have risen 16% over the past six years, and nearly 40% of hospitals operate at a deficit. Although more than 80% of appealed denials are ultimately overturned, limited resources prevent many systems from pursuing them—leaving millions in revenue on the table. Increasingly, hospitals are turning to AI-driven solutions like Iodine's to address these gaps and ensure financial sustainability in an increasingly complex payer environment. 'Iodine's pre-bill technology has delivered measurable ROI for AdventHealth,' said Dr. Christopher Riccard, VP of Hospital Medicine and CDI at AdventHealth. 'We've seen a meaningful lift in high-impact queries that drive both revenue and quality outcomes. The ability to prioritize the right cases—not just more—has transformed our teams' productivity and strengthened our financial performance.' The solution leverages proven AI to pinpoint patient records with the greatest financial impact, exclude low-value cases, and validate DRG and ICD-10 codes by identifying missing documentation, recommending more appropriate codes, and surfacing alternative principal diagnoses. It also identifies post-discharge query opportunities, flags diagnoses lacking sufficient physician support, and detects financially significant quality events—such as HACs and PSIs—that may warrant documentation or coding updates. Each recommendation is backed by relevant clinical context, enabling reviewers to act with speed, accuracy, and confidence. Recognizing the persistent staffing challenges facing health systems, Iodine will also offer tech-enabled services to help close pre-bill revenue gaps. 'Hospitals are navigating rising denial rates and shrinking margins,' said William Chan, CEO of Iodine Software. 'We remain focused on our mission to be a true partner in helping health systems get reimbursed accurately for the care they provide. With enhanced pre-bill capabilities and flexible, outcomes-based pricing and service models, we are making it easier for healthcare leaders to adopt the tools they need to safeguard financial performance and support long-term stability.' Today, hundreds of health systems rely on Iodine to improve cycle revenue performance—reducing review times by 63% and generating millions in incremental impact annually. As Chan notes, 'In an environment where every dollar counts, we're delivering the tools hospitals need to protect their margins—and their mission.' For more information on Iodine Software and its industry-leading AI solutions, visit About AdventHealth AdventHealth is a connected network of care that helps people feel whole – body, mind and spirit. More than 100,000 team members across a national footprint provide whole-person care to nearly nine million people annually through more than 2,000 care sites that include hospitals, physician practices, ambulatory surgery centers, outpatient clinics, home health agencies, hospice centers, the AdventHealth app and more. Our wholistic approach to improving the health and prosperity of our communities is inspired by our mission to extend the healing ministry of Christ. About Iodine Software Iodine Software is the leader in AI-powered clinical intelligence, helping healthcare organizations capture the full value of patient care. Our solutions drive accurate documentation, optimize reimbursement, reduce administrative burden, and help prevent costly denials—powering more efficient revenue cycle operations. For over a decade, health systems have trusted Iodine to apply the right AI—whether machine learning, deep learning, GenAI and Agentic AI— to the right use case, consistently delivering reliable, high-impact outcomes. Iodine's proprietary Clinical Intelligence Engine, CognitiveML, mirrors clinical judgment and draws insights from one of the largest sets of inpatient clinical data in the country. The platform continuously reviews every patient chart to deliver the most holistic, real-time clinical snapshot available. Recognized as Best in KLAS, Iodine's Clinical Intelligence Suite scales clinical intelligence through solutions like AwareCDI, AwareUM, and AwarePre-Bill, helping healthcare organizations achieve financial returns and improve quality. Learn more at
Yahoo
13-05-2025
- Business
- Yahoo
Iodine Software Expands Executive Team with New Chief Commercial Officer to Scale Clinical Intelligence AI Platform for Health Systems
Following $2.1B in recovered reimbursement in 2024, Iodine strengthens its leadership to meet growing demand for AI solutions that drive proven financial impact. AUSTIN, Texas, May 13, 2025--(BUSINESS WIRE)--Iodine Software, the leading AI-powered revenue cycle company, today announced the appointment of Valerie Mondelli, RPh, MBA, as Chief Commercial Officer (CCO). Mondelli joins the company's executive leadership team at a pivotal time, as Iodine prepares to scale its impact following a landmark year in which it helped health systems recover more than $2.1 billion in reimbursement in 2024. With more health systems under increasing financial strain and AI adoption on the rise, Iodine is one of the few healthcare AI companies delivering clear, quantifiable results. A recent McKinsey report noted that only 23% of healthcare executives said their AI vendors demonstrated positive ROI. In contrast, Iodine partners routinely recover millions in right-sized reimbursement, reduce denials, and streamline revenue cycle operations. "As the healthcare market becomes more crowded with AI vendors, health systems need partners who don't just promise impact—but prove it," said William Chan, CEO and Co-Founder of Iodine Software. "Valerie brings decades of commercial leadership and a deep understanding of healthcare's financial pressures. Her experience and customer-first mindset will help us align our teams and scale our growth strategy for even greater impact." Mondelli brings more than 25 years of commercial leadership experience across healthcare, retail pharmacy, payers, pharmaceutical manufacturers, and health IT. Most recently, she served as Chief Commercial Officer at RevSpring, where she led its transformation into a digital engagement and payments platform. Her experience spans companies like Eli Lilly, RelayHealth (McKesson), and FiServ, and in 2023, she was named one of Drug Store News' Top Women in Business. "Hospitals are under immense pressure—grappling with rising denials, financial strain, and mounting complexity," said Valerie Mondelli, Chief Commercial Officer of Iodine Software. "What sets Iodine apart is its ability to turn deep clinical intelligence into financial impact. By helping health systems recover earned revenue and prevent denials, we're not just improving margins—we're reinforcing their ability to deliver on their care mission. I'm proud to join a team so committed to solving healthcare's hardest problems." Hundreds of hospitals and health systems trust CognitiveML™—Iodine's proprietary Clinical Intelligence AI engine—purpose-built for healthcare's complexity. By mirroring clinical judgment and leveraging one of the nation's largest inpatient datasets, CognitiveML™ delivers the most complete picture of patient care. It uncovers hidden revenue by ensuring accurate documentation and coding—driving measurable financial and improved quality outcomes: 63% reduction in medical review time (from 15 to 5 minutes) $15M annualized impact through accurate level-of-care adjustments 139% increase in incremental financial return per facility, averaging $1.5M About Iodine Software Iodine Software is the leader in AI-powered clinical intelligence, helping healthcare organizations capture the full value of patient care. Our solutions drive accurate documentation, optimize reimbursement, reduce administrative burden, and help prevent costly denials—powering more efficient revenue cycle operations. For over a decade, health systems have trusted Iodine to apply the right AI—whether machine learning, deep learning, GenAI and Agentic AI— to the right use case, consistently delivering reliable, high-impact outcomes. Iodine's proprietary Clinical Intelligence Engine, CognitiveML, mirrors clinical judgment and draws insights from one of the largest sets of inpatient clinical data in the country. The platform continuously reviews every patient chart to deliver the most holistic, real-time clinical snapshot available. Recognized as Best in KLAS, Iodine's Clinical Intelligence Suite scales clinical intelligence through solutions like AwareCDI, AwareUM, and AwarePre-Bill, helping healthcare organizations achieve financial returns and improve quality. Learn more at View source version on Contacts Evan ScarduffaIodine@
Business Wire
13-05-2025
- Business
- Business Wire
Iodine Software Expands Executive Team with New Chief Commercial Officer to Scale Clinical Intelligence AI Platform for Health Systems
AUSTIN, Texas--(BUSINESS WIRE)--Iodine Software, the leading AI-powered revenue cycle company, today announced the appointment of Valerie Mondelli, RPh, MBA, as Chief Commercial Officer (CCO). Mondelli joins the company's executive leadership team at a pivotal time, as Iodine prepares to scale its impact following a landmark year in which it helped health systems recover more than $2.1 billion in reimbursement in 2024. With more health systems under increasing financial strain and AI adoption on the rise, Iodine is one of the few healthcare AI companies delivering clear, quantifiable results. A recent McKinsey report noted that only 23% of healthcare executives said their AI vendors demonstrated positive ROI. In contrast, Iodine partners routinely recover millions in right-sized reimbursement, reduce denials, and streamline revenue cycle operations. 'As the healthcare market becomes more crowded with AI vendors, health systems need partners who don't just promise impact—but prove it,' said William Chan, CEO and Co-Founder of Iodine Software. 'Valerie brings decades of commercial leadership and a deep understanding of healthcare's financial pressures. Her experience and customer-first mindset will help us align our teams and scale our growth strategy for even greater impact.' Mondelli brings more than 25 years of commercial leadership experience across healthcare, retail pharmacy, payers, pharmaceutical manufacturers, and health IT. Most recently, she served as Chief Commercial Officer at RevSpring, where she led its transformation into a digital engagement and payments platform. Her experience spans companies like Eli Lilly, RelayHealth (McKesson), and FiServ, and in 2023, she was named one of Drug Store News' Top Women in Business. 'Hospitals are under immense pressure—grappling with rising denials, financial strain, and mounting complexity,' said Valerie Mondelli, Chief Commercial Officer of Iodine Software. 'What sets Iodine apart is its ability to turn deep clinical intelligence into financial impact. By helping health systems recover earned revenue and prevent denials, we're not just improving margins—we're reinforcing their ability to deliver on their care mission. I'm proud to join a team so committed to solving healthcare's hardest problems.' Hundreds of hospitals and health systems trust CognitiveML™—Iodine's proprietary Clinical Intelligence AI engine—purpose-built for healthcare's complexity. By mirroring clinical judgment and leveraging one of the nation's largest inpatient datasets, CognitiveML™ delivers the most complete picture of patient care. It uncovers hidden revenue by ensuring accurate documentation and coding—driving measurable financial and improved quality outcomes: 63% reduction in medical review time (from 15 to 5 minutes) $15M annualized impact through accurate level-of-care adjustments 139% increase in incremental financial return per facility, averaging $1.5M About Iodine Software Iodine Software is the leader in AI-powered clinical intelligence, helping healthcare organizations capture the full value of patient care. Our solutions drive accurate documentation, optimize reimbursement, reduce administrative burden, and help prevent costly denials—powering more efficient revenue cycle operations. For over a decade, health systems have trusted Iodine to apply the right AI—whether machine learning, deep learning, GenAI and Agentic AI— to the right use case, consistently delivering reliable, high-impact outcomes. Iodine's proprietary Clinical Intelligence Engine, CognitiveML, mirrors clinical judgment and draws insights from one of the largest sets of inpatient clinical data in the country. The platform continuously reviews every patient chart to deliver the most holistic, real-time clinical snapshot available. Recognized as Best in KLAS, Iodine's Clinical Intelligence Suite scales clinical intelligence through solutions like AwareCDI, AwareUM, and AwarePre-Bill, helping healthcare organizations achieve financial returns and improve quality. Learn more at
Daily Mirror
21-04-2025
- Science
- Daily Mirror
Inside most secret radioactive site in US said to be 'Chernobyl in making'
The Hanford Site in Washington saw more than 400 billion gallons of contaminated liquid dumped into its ground during its use - and now it could be developed as an AI development hub A huge radioactive site which is planted on almost 600 acres of desert land has been compared to an "underground Chernobyl" with warnings that it is a disaster waiting to happen. The Hanford Site in Washington, US, was constructed during World War II and is known as one of the country's most radioactive chemical contamination sites. The area was built as part of the Manhattan Project, where workers made plutonium to put together an explosive which was eventually set off in Nagasaki, Japan, on August 9, 1945. According to experts, the site's most hazardous waste is hidden in the tanks and unlined trenches. Washington's Department of Ecology has warned that there are 177 leaky storage tanks buried on the property, holding 56 million gallons of radioactive waste. Now, the site has been proposed as a potential location for AI development by the Department of Energy. Richland has been included on the list as it is home to the Department of Energy's Pacific Northwest National Laboratory, which could result in a partnership with developers on advanced hardware for next-generation data centres and power systems needed to run them. The 295 acres in Richland, however, is former Hanford nuclear site land, which was transferred to the Department via the Tri-City Development Council to the city of Richland in 2015 to be developed as part of a new Advanced Clean Energy Park. But the land has a long, deadly, history. The toxic facility was so dangerous that it was nicknamed "death mile" in 1985 after local farmers were being diagnosed with cancers. The string of incidents was linked back to the residents breathing in the chemical, Iodine 131. Iodine 131 is used in medicine to treat thyroid cancer and hyperthyroidism. Government officials gave locals a mere 30 days to leave the area, with residents being paid for their land. However, indigenous tribes weren't given any compensation. The War Powers Act which was put in place prior to its 1973 resolution allowed the government to use land for military purposes. Under the act, President Franklin Delano Roosevelt acquired over 600 square miles of land. The shock request saw up to 55,000 men and women taken to the area to start work on the undercover development. A lot of them knew very little about what they were working on, with most being unaware it was for the war. It was reported that only 5 per cent actually knew why they were hired. The secret workers were given access to almost ten dining halls, a hospital, a post office, barbershops and a cinema. The Department of Ecology revealed that they were also given entry into dance halls and bowling alleys to keep them entertained outside of working hours. It was reported that its first full-scale plutonium production reactor was finalised within 13 months. The operation was launched in 1944. Physicist Leona Libby, 23, and her team created the first nuclear chain reaction which later helped create the bomb. Once the explosive was released, the workers were given further insight into the circumstances behind the project. After WWII had finished, the production site continued its operation during the Cold War. In 1963, the last reactor was constructed. When the site was in use, more than 400 billion gallons of contaminated liquids were dumped into the ground. According to the Department of Ecology, that dumped material then came into contact with groundwater and even reached parts of the Columbia River. The Department of Ecology was launched in 1970 and assessed any concerns surrounding the site. By 1989, it was forced to close its doors due to a potential red flag which was highlighted in 1987. Despite, discussions about clean-up efforts taking place, the Hanford Site is still viewed as an environmental concern.
Yahoo
21-04-2025
- Business
- Yahoo
Arista Advanced Pet Care Opens Their First Specialty and Emergency Hospital in Atlanta, Georgia
Revolutionary Veterinary Specialty & 24/7 Emergency Care Comes to Sandy Springs, Marking the Start of National Expansion ATLANTA, April 21, 2025--(BUSINESS WIRE)--Arista Advanced Pet Care announces the grand opening of its first specialty referral and emergency veterinary hospital in Atlanta, Georgia, on Monday, April 21, 2025. Located at 5525 Interstate Pkwy N, Atlanta, GA 30328, Arista Atlanta is redefining specialty and emergency veterinary care with a unique veterinarian-led ownership model, ensuring a sustainable and collaborative approach to advanced pet healthcare. Atlanta, a city known for its thriving healthcare innovation and medical excellence, serves as the perfect launchpad for Arista's first hospital into the specialty veterinary space. With increasing demand for advanced pet healthcare, Arista is at the forefront of evolving specialty medicine, by introducing the Care Navigation function. Care Navigators ensure a seamless and transparent process for both clients and referring veterinarians. Arista Advanced Pet Care is created by veterinarians, led by veterinarians, and owned by veterinarians. Reimagining the traditional specialty and emergency care model by empowering veterinary professionals with a meaningful stake in their hospitals ensures commitment to excellence and the autonomy to always do the right thing. "Arista Advanced Pet Care is bringing a much-needed transformation to the veterinary specialty and emergency sector," said Jennifer Welser, DVM, DACVO, President of Arista Advanced Pet Care. "By giving veterinary professionals ownership in their practices, we are fostering a culture of excellence, innovation, and accountability—ultimately leading to better patient care and a superior experience for pet owners, primary care practitioners and the Arista team." Andy Anderson, DVM, DACVS, Executive Chairman of Affinity Veterinary Partners, parent company of Arista Advanced Pet Care, adds, "Our priority in creating Arista was to deliver the highest level of veterinary care in a compassionate, transparent, and efficient manner. We are thrilled to introduce our proven model to the specialty medicine sector, providing an unparalleled support system for pet owners and primary care veterinarians." Located in Sandy Springs, Arista Atlanta is equipped with the state-of-the-art veterinary technology and a team of highly skilled, board-certified specialists committed to delivering best-in-class patient care. The hospital provides a comprehensive range of specialty and emergency services, including: Internal Medicine Surgery Oncology Emergency & Critical Care I-131 (Radioactive Iodine Therapy) Arista Atlanta brings together a world-class team of veterinary professionals, each with a distinguished background in their field: Amirah Nasr, DVM, DACVIM (Internal Medicine)– Board-certified in internal medicine, specializing in gastroenterology, endocrinology, infectious disease, and autoimmune disorders. Sarah Camp, DVM – Emergency veterinarian dedicated to stabilizing critically ill and injured pets with extensive experience in urgent and trauma care. Brolin Evans, DVM, DACVIM (Oncology) – Board-certified veterinary oncologist specializing in cutting-edge cancer treatments, including novel immunotherapies and electrochemotherapy. Abby Lockwood, DVM, DACVS – A skilled veterinary surgeon with expertise in orthopedic, soft tissue, and neurological procedures, including oncologic and trauma surgery. With pet ownership on the rise and growing demand for specialized veterinary care, Arista is strategically expanding into key markets to meet the needs of pet owners and veterinary professionals alike. Following the Atlanta opening, Arista will launch additional locations beginning with Dallas, TX (2025) with more cities on the horizon. "The future of veterinary medicine is deeply tied to patient-centric care, innovation, and the well-being of the professionals who dedicate their lives to it," added Dr. Welser. "Arista is setting a new precedent—one where specialists have the autonomy, support, and infrastructure to provide unparalleled care while shaping the future of the profession." The official Grand Opening of Arista Atlanta will take place on April 21, 2025. For more information, visit or contact info@ About Arista Advanced Pet Care Arista Advanced Pet Care is a multispecialty referral and 24/7 emergency veterinary hospital group dedicated to revolutionizing specialty medicine through a shared ownership model. As part of Affinity Veterinary Partners, Arista draws from the proven success of a veterinarian-led approach to create an empowering environment for veterinary teams while providing exceptional care to pets in need. With an ambitious national expansion plan, Arista is poised to redefine the future of specialty veterinary care. For more information, visit View source version on Contacts For media inquiries, please contact a Strauss PR team member:Allie Lesiuk - allie@ - 817-733-3766Kristin Garcia - kristin@ - 214-264-5962 Sign in to access your portfolio
